271 related articles for article (PubMed ID: 29054727)
1. Evaluation of immune responses in dogs to oral rabies vaccine under field conditions.
Smith TG; Millien M; Vos A; Fracciterne FA; Crowdis K; Chirodea C; Medley A; Chipman R; Qin Y; Blanton J; Wallace R
Vaccine; 2019 Aug; 37(33):4743-4749. PubMed ID: 29054727
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs.
Freuling CM; Eggerbauer E; Finke S; Kaiser C; Kaiser C; Kretzschmar A; Nolden T; Ortmann S; Schröder C; Teifke JP; Schuster P; Vos A; Mettenleiter TC; Müller T
Vaccine; 2019 Aug; 37(33):4750-4757. PubMed ID: 29042202
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
[TBL] [Abstract][Full Text] [Related]
4. Review of Oral Rabies Vaccination of Dogs and Its Application in India.
Yale G; Lopes M; Isloor S; Head JR; Mazeri S; Gamble L; Dukpa K; Gongal G; Gibson AD
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062358
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Oral Rabies Vaccine Strain SPBN GASGAS in Local Dogs in Bali, Indonesia.
Megawati Saputra IL; Suwarno S; Husein WF; Suseno PP; Prayoga IMA; Vos A; Arthawan IM; Schoonman L; Weaver J; Zainuddin N
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376704
[TBL] [Abstract][Full Text] [Related]
6. Costs and effectiveness of alternative dog vaccination strategies to improve dog population coverage in rural and urban settings during a rabies outbreak.
Undurraga EA; Millien MF; Allel K; Etheart MD; Cleaton J; Ross Y; ; Wallace RM
Vaccine; 2020 Sep; 38(39):6162-6173. PubMed ID: 32616327
[TBL] [Abstract][Full Text] [Related]
7. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and Effectiveness Studies with Oral Vaccination of Free-Roaming Dogs against Rabies in Thailand.
Chanachai K; Wongphruksasoong V; Vos A; Leelahapongsathon K; Tangwangvivat R; Sagarasaeranee O; Lekcharoen P; Trinuson P; Kasemsuwan S
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805404
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Iophenoxic Acid Analogues in Small Indian Mongoose (Herpestes Auropunctatus) Sera for Use as an Oral Rabies Vaccination Biological Marker.
Berentsen AR; Sugihara RT; Payne CG; Leinbach I; Volker SF; Vos A; Ortmann S; Gilbert AT
J Vis Exp; 2019 May; (147):. PubMed ID: 31205294
[TBL] [Abstract][Full Text] [Related]
10. Challenges to controlling rabies in skunk populations using oral rabies vaccination: A review.
Wohlers A; Lankau EW; Oertli EH; Maki J
Zoonoses Public Health; 2018 Jun; 65(4):373-385. PubMed ID: 29633545
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of the Oral Rabies Vaccine Strain SPBN GASGAS in Dogs Under Field Settings in Namibia.
Molini U; Hassel R; Ortmann S; Vos A; Loschke M; Shilongo A; Freuling CM; Müller T
Front Vet Sci; 2021; 8():737250. PubMed ID: 34760958
[TBL] [Abstract][Full Text] [Related]
12. Rabies DNA vaccination by the intranasal route in dogs.
Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral rabies vaccination in individual age groups of juvenile red foxes.
Papatheodorou DP; Tasioudi KE; Korou LM; Georgiou VL; Markantonatos G; Iliadou P; Kirtzalidou A; Katsifa A; Ztrivas S; Bechtsi G; Tzani M; Chondrokouki E; Mangana-Vougiouka O
Vet Microbiol; 2018 Nov; 226():59-63. PubMed ID: 30389044
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes.
Freuling CM; Kamp VT; Klein A; Günther M; Zaeck L; Potratz M; Eggerbauer E; Bobe K; Kaiser C; Kretzschmar A; Ortmann S; Schuster P; Vos A; Finke S; Müller T
Viruses; 2019 Aug; 11(9):. PubMed ID: 31461981
[No Abstract] [Full Text] [Related]
15. Design of different strategies of multivalent DNA-based vaccination against rabies and canine distemper in mice and dogs.
Touihri L; Ahmed SB; Chtourou Y; Daoud R; Bahloul C
Virol J; 2012 Dec; 9():319. PubMed ID: 23270301
[TBL] [Abstract][Full Text] [Related]
16. Impact of community-delivered SMS alerts on dog-owner participation during a mass rabies vaccination campaign, Haiti 2017.
Cleaton JM; Wallace RM; Crowdis K; Gibson A; Monroe B; Ludder F; Etheart MD; Natal Vigilato MA; King A
Vaccine; 2018 Apr; 36(17):2321-2325. PubMed ID: 29580642
[TBL] [Abstract][Full Text] [Related]
17. Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases.
Head JR; Vos A; Blanton J; Müller T; Chipman R; Pieracci EG; Cleaton J; Wallace R
Sci Rep; 2019 May; 9(1):6783. PubMed ID: 31043646
[TBL] [Abstract][Full Text] [Related]
18. Thermotolerance of an inactivated rabies vaccine for dogs.
Lankester FJ; Wouters PAWM; Czupryna A; Palmer GH; Mzimbiri I; Cleaveland S; Francis MJ; Sutton DJ; Sonnemans DGP
Vaccine; 2016 Nov; 34(46):5504-5511. PubMed ID: 27729174
[TBL] [Abstract][Full Text] [Related]
19. Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines.
Blanton JD; Self J; Niezgoda M; Faber ML; Dietzschold B; Rupprecht C
Vaccine; 2007 Oct; 25(42):7296-300. PubMed ID: 17826874
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of specific ELISA and RFFIT antibody assays in the assessment of dog immunity against rabies.
Bahloul C; Taieb D; Kaabi B; Diouani MF; Ben Hadjahmed S; Chtourou Y; Imen B'Chir B; Dellagi K
Epidemiol Infect; 2005 Aug; 133(4):749-57. PubMed ID: 16050522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
